Leucine Deprivation Increases Hepatic Insulin Sensitivity Via GCN2/mTOR/S6K1 and AMPK Pathways.

Fei Xiao,Zhiying Huang,Houkai Li,Junjie Yu,Chunxia Wang,Shanghai Chen,Qingshu Meng,Ying Cheng,Xiang Gao,Jia Li,Yong Liu,Feifan Guo
DOI: https://doi.org/10.2337/db10-1246
IF: 7.7
2011-01-01
Diabetes
Abstract:OBJECTIVE-We have previously shown that serum insulin levels decrease threefold and blood glucose levels remain normal in mice fed a leucine-deficient diet, suggesting increased insulin sensitivity. The goal of the current study is to investigate this possibility and elucidate the underlying cellular mechanisms.RESEARCH DESIGN AND METHODS-Changes in metabolic parameters and expression of genes and proteins involved in regulation of insulin sensitivity were analyzed in mice, human HepG2 cells, and mouse primary hepatocytes under leucine deprivation.RESULTS-We show that leucine deprivation improves hepatic insulin sensitivity by sequentially activating general control non-derepressible (GCN)2 and decreasing mammalian target of rapamycin/S6K1 signaling. In addition, we show that activation of AMP-activated protein kinase also contributes to leucine deprivation-increased hepatic insulin sensitivity. Finally, we show that leucine deprivation improves insulin sensitivity under insulin-resistant conditions.CONCLUSIONS-This study describes mechanisms underlying increased hepatic insulin sensitivity under leucine deprivation. Furthermore, we demonstrate a novel function for GCN2 in the regulation of insulin sensitivity. These observations provide a rationale for short-term dietary restriction of leucine for the treatment of insulin resistance and associated metabolic diseases. Diabetes 60:746-756, 2011
What problem does this paper attempt to address?